145 related articles for article (PubMed ID: 38370290)
1. Clinicopathological Features and Treatment Outcomes of Male Breast Cancer in Pakistani Population: A 10-Year Retrospective Cross-Sectional Study.
Khalid IB; Sarwar A; Khalid HB; Sajjad B; Rehman B; Parvaiz MA
Breast Cancer (Auckl); 2024; 18():11782234241233120. PubMed ID: 38370290
[TBL] [Abstract][Full Text] [Related]
2. Male breast cancer: Outcome with adjuvant treatment.
Yadav BS; Sharma SC; Singh R; Dahiya D; Ghoshal S
J Cancer Res Ther; 2020; 16(6):1287-1293. PubMed ID: 33342786
[TBL] [Abstract][Full Text] [Related]
3. Breast Cancer in Men: a Report from the Department of Radiation Oncology in Kermanshah Province, Iran.
Amirifard N; Sadeghi E
Asian Pac J Cancer Prev; 2016; 17(5):2593-6. PubMed ID: 27268636
[TBL] [Abstract][Full Text] [Related]
4. Male Breast Cancer and Hyperestrogenemia: A Thirteen-Year Review.
Tariq KB; Al-Saffar F; Ibrahim S; Pham D; Farhangi A; Rana F; Zaiden R
World J Oncol; 2014 Apr; 5(2):55-61. PubMed ID: 29147378
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological characteristics and prognosis of metaplastic breast cancer versus triple-negative invasive ductal carcinoma: a retrospective analysis.
Yang X; Tang T; Zhou T
World J Surg Oncol; 2023 Nov; 21(1):364. PubMed ID: 37996840
[TBL] [Abstract][Full Text] [Related]
6. Male breast cancer in the veterans affairs population: a comparative analysis.
Nahleh ZA; Srikantiah R; Safa M; Jazieh AR; Muhleman A; Komrokji R
Cancer; 2007 Apr; 109(8):1471-7. PubMed ID: 17342768
[TBL] [Abstract][Full Text] [Related]
7. Metaplastic Breast Carcinoma: Clinicopathological Parameters and Prognostic Profile.
Haroon S; Zia S; Shirazi UA; Ahmed O; Asghar IA; Diwan MA; Afzal A; Irfan M; Ali SJ; Hashmi AA
Cureus; 2021 Apr; 13(4):e14347. PubMed ID: 33987039
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
9. Triple negative breast cancer in Moroccan women: clinicopathological and therapeutic study at the National Institute of Oncology.
Rais G; Raissouni S; Aitelhaj M; Rais F; Naciri S; Khoyaali S; Abahssain H; Bensouda Y; Khannoussi B; Mrabti H; Errihani H
BMC Womens Health; 2012 Oct; 12():35. PubMed ID: 23039971
[TBL] [Abstract][Full Text] [Related]
10. Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer.
Jung SY; Kim HY; Nam BH; Min SY; Lee SJ; Park C; Kwon Y; Kim EA; Ko KL; Shin KH; Lee KS; Park IH; Lee S; Kim SW; Kang HS; Ro J
Breast Cancer Res Treat; 2010 Apr; 120(3):627-37. PubMed ID: 20143153
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and Immunohistochemical Characteristics in Male Breast Cancer: A Retrospective Case Series.
Masci G; Caruso M; Caruso F; Salvini P; Carnaghi C; Giordano L; Miserocchi V; Losurdo A; Zuradelli M; Torrisi R; Di Tommaso L; Tinterri C; Testori A; Garcia-Etienne CA; Gatzemeier W; Santoro A
Oncologist; 2015 Jun; 20(6):586-92. PubMed ID: 25948676
[TBL] [Abstract][Full Text] [Related]
12. The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients.
Bae SY; Lee SK; Koo MY; Hur SM; Choi MY; Cho DH; Kim S; Choe JH; Lee JE; Kim JH; Kim JS; Nam SJ; Yang JH
Breast Cancer Res Treat; 2011 Apr; 126(2):471-8. PubMed ID: 21287362
[TBL] [Abstract][Full Text] [Related]
13. The clinical features and prognosis of patients with mucinous breast carcinoma compared with those with infiltrating ductal carcinoma: a population-based study.
Zhou X; Zheng Z; Li Y; Zhao W; Lin Y; Zhang J; Sun Q
BMC Cancer; 2021 May; 21(1):536. PubMed ID: 33975551
[TBL] [Abstract][Full Text] [Related]
14. Clinical Features of Male Breast Cancer: Experiences from Seven Institutions Over 20 Years.
Hong JH; Ha KS; Jung YH; Won HS; An HJ; Lee GJ; Kang D; Park JC; Park S; Byun JH; Suh YJ; Kim JS; Park WC; Jung SS; Park IY; Chung SM; Woo IS
Cancer Res Treat; 2016 Oct; 48(4):1389-1398. PubMed ID: 27121722
[TBL] [Abstract][Full Text] [Related]
15. Different prognosis by subtype in the early mucinous breast cancer: a SEER population-based analysis.
Lian W; Zheng J; Chen D
Transl Cancer Res; 2020 Oct; 9(10):5969-5978. PubMed ID: 35117209
[TBL] [Abstract][Full Text] [Related]
16. Improved anti-tumor response rate with decreased cardiotoxicity of non-pegylated liposomal doxorubicin compared with conventional doxorubicin in first-line treatment of metastatic breast cancer in patients who had received prior adjuvant doxorubicin: results of a retrospective analysis.
Batist G; Harris L; Azarnia N; Lee LW; Daza-Ramirez P
Anticancer Drugs; 2006 Jun; 17(5):587-95. PubMed ID: 16702817
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor expression in male breast cancer predicts inferior outcome and poor response to tamoxifen treatment.
Wenhui Z; Shuo L; Dabei T; Ying P; Zhipeng W; Lei Z; Xiaohui H; Jingshu G; Hongtao S; Qingyuan Z
Eur J Endocrinol; 2014 Oct; 171(4):527-33. PubMed ID: 25069458
[TBL] [Abstract][Full Text] [Related]
18. Metaplastic breast cancer: clinicopathological features and its prognosis.
Lee H; Jung SY; Ro JY; Kwon Y; Sohn JH; Park IH; Lee KS; Lee S; Kim SW; Kang HS; Ko KL; Ro J
J Clin Pathol; 2012 May; 65(5):441-6. PubMed ID: 22412048
[TBL] [Abstract][Full Text] [Related]
19. Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.
Marmor S; Hui JYC; Huang JL; Kizy S; Beckwith H; Blaes AH; Rueth NM; Tuttle TM
Cancer; 2017 Aug; 123(16):3015-3021. PubMed ID: 28382636
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant Chemotherapy for Metaplastic Breast Cancer: Response Rates, Management, and Outcomes.
Haque W; Verma V; Schwartz MR; Lim B; Mangalampalli N; Butler EB; Teh BS
Clin Breast Cancer; 2022 Jul; 22(5):e691-e699. PubMed ID: 35193807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
